Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Regeneron Pharmaceuticals, Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: BiotechnologySector: Healthcare

Fair Value Summary

Current Price$746.36
5Y Range428.83 – 652.09
5Y Selected540.46
(-) Safety Margin68.14%
5Y Buy Price$172.19
Upside (to Buy Price)-76.93%
10Y Range531.54 – 800.52
10Y Selected666.03
(-) Safety Margin68.14%
10Y Buy Price$212.20
Upside (to Buy Price)-71.57%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.2257
Revenue R2 (10Y)0.8068
Net Income R2 (5Y)0.0401
Net Income R2 (10Y)0.5402
EBITDA R2 (5Y)0.0331
EBITDA R2 (10Y)0.4986
FCF R2 (5Y)0.0020
FCF R2 (10Y)0.5767
Safety Score0.3186

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth13.50%12.45%11.39%10.33%9.28%8.22%7.17%6.11%5.06%4.00%
Revenue16,119.4018,125.4920,189.9122,276.3224,343.1826,344.8228,232.9429,958.3531,472.9432,731.85
EBITDA4,772.985,366.995,978.276,596.067,208.067,800.758,359.838,870.729,319.209,691.96
D&A-428.67-482.02-536.92-592.41-647.37-700.60-750.82-796.70-836.98-870.46
EBIT4,344.314,884.975,441.356,003.656,560.697,100.157,609.018,074.028,482.228,821.50
Pro forma Taxes-594.45-668.44-744.57-821.51-897.73-971.55-1,041.18-1,104.81-1,160.67-1,207.09
NOPAT3,749.854,216.534,696.785,182.145,662.956,128.606,567.836,969.217,321.557,614.41
Capital Expenditures-999.36-1,123.73-1,251.72-1,381.07-1,509.21-1,633.31-1,750.37-1,857.34-1,951.24-2,029.29
NWC Investment-749.98-784.67-807.48-816.08-808.44-782.93-738.53-674.88-592.42-492.42
(+) D&A428.67482.02536.92592.41647.37700.60750.82796.70836.98870.46
Free Cash Flow2,429.192,790.153,174.503,577.393,992.684,412.964,829.755,233.695,614.875,963.16
Diluted Shares Outstanding110,200,000.00110,200,000.00110,200,000.00110,200,000.00110,200,000.00110,200,000.00110,200,000.00110,200,000.00110,200,000.00110,200,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.40%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF2,408.132,680.602,795.522,887.602,954.052,992.733,002.242,982.032,932.422,854.61
Raw: 61,073.64
43,261.27
Raw: 91,215.03
41,804.98

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value56,987.1770,294.90
(-) Net Debt184.80184.80
Equity Value56,802.3770,110.10
(/) Shares Out110.20110.20
Fair Value$515.45$636.21
(-) Safety Margin68.14%68.14%
Buy Price$164.22$202.70
Current Price$746.36$746.36
Upside (to Buy Price)-78.00%-72.84%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.90%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF2,405.932,669.372,758.532,823.512,862.252,873.382,856.332,811.342,739.462,642.55
Raw: 49,650.65
33,921.76
Raw: 74,154.51
31,317.99

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value47,441.3558,760.64
(-) Net Debt184.80184.80
Equity Value47,256.5558,575.84
(/) Shares Out110.20110.20
Fair Value$428.83$531.54
(-) Safety Margin68.14%68.14%
Buy Price$136.62$169.35
Current Price$746.36$746.36
Upside (to Buy Price)-81.69%-77.31%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.90%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF2,410.352,691.982,833.362,953.763,049.683,118.193,157.043,164.803,140.943,085.88
Raw: 79,093.66
58,106.37
Raw: 118,128.39
58,796.04

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value72,045.4988,402.02
(-) Net Debt184.80184.80
Equity Value71,860.6988,217.22
(/) Shares Out110.20110.20
Fair Value$652.09$800.52
(-) Safety Margin68.14%68.14%
Buy Price$207.76$255.05
Current Price$746.36$746.36
Upside (to Buy Price)-72.16%-65.83%

Reverse DCF: Market Implied Growth

Current Price$746.36
WACC Used9.1%
IMPLIED REVENUE GROWTH147.64%
Metric2027202820292030203120322033203420352036
Implied Revenue35,283.8387,378.30216,387.15535,869.891,327,049.853,286,359.918,138,474.5420,154,447.3949,911,288.35123,602,332.36
Constant Implied Growth147.64%147.64%147.64%147.64%147.64%147.64%147.64%147.64%147.64%147.64%
Implied Free Cash Flow3.538.7421.6453.59132.70328.64813.852,015.444,991.1312,360.23
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF3.287.0516.0136.3482.49187.25425.04964.812,190.044,971.22

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$375.488.09%$399.206.32%
20182018-12-31$373.5017.97%$509.6836.46%
20172017-12-31$375.9622.59%$341.02-9.29%
20162016-12-31$367.0924.99%$349.95-4.67%
20152015-12-31$542.8714.42%$160.56-70.42%
20142014-12-31$410.2513.80%$101.51-75.26%
20132013-12-31$275.2420.62%$137.62-50.00%
20122012-12-31$171.0724.89%$-48.43-128.31%
20112011-12-31$55.4330.61%$-112.08-302.21%
20102010-12-31$32.8346.53%$-4.15-112.63%
20092009-12-31$24.1843.51%$-169.23-799.89%
20082008-12-31$18.3635.70%$-93.56-609.60%
20072007-12-31$24.1528.58%$10.88-54.94%
20062006-12-31$20.0725.23%$15.37-23.42%
20052005-12-31$15.9041.67%$-47.81-400.68%
20042004-12-31$9.2137.98%$-29.49-420.19%
20032003-12-31$14.713.91%$-14.56-198.99%
20022002-12-31$18.51-0.48%$-51.29-377.12%
20012001-12-31$28.1616.03%$-44.86-259.29%
20002000-12-31$35.2734.73%$-57.30-262.45%
19991999-12-31$12.7520.25%$-21.13-265.75%
19981998-12-31$7.38-11.53%$-3.29-144.59%
19971997-12-31$8.56-25.71%$-0.43-104.98%
19961996-12-31$16.13-12.61%$-8.86-154.93%
19951995-12-31$13.2510.42%$-24.42-284.30%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$665.66
Median
$645.86
10th Percentile
$531.53
90th Percentile
$819.43

Fair Value Distribution

$438.67 - $487.87
27
$487.87 - $537.06
96
$537.06 - $586.26
163
$586.26 - $635.45
183
$635.45 - $684.64
157
$684.64 - $733.84
137
$733.84 - $783.03
87
$783.03 - $832.23
59
$832.23 - $881.42
35
$881.42 - $930.62
25
$930.62 - $979.81
8
$979.81 - $1,029.01
6
$1,029.01 - $1,078.20
5
$1,078.20 - $1,127.40
5
$1,127.40 - $1,176.59
3
$1,176.59 - $1,225.78
2
$1,225.78 - $1,274.98
0
$1,274.98 - $1,324.17
0
$1,324.17 - $1,373.37
1
$1,373.37 - $1,422.56
1